The European Centre for Disease Prevention and Control has now matched a season of sustained heat to a measurable rise in mosquito-borne illness. As of the first week of August 2026, forty-nine NUTS-3 areas across seven European countries have reported West Nile virus circulation, and the autochthonous dengue, chikungunya and Zika transmission events that Italy, France and Spain have each recorded in recent summers are running ahead of last year's curve. This piece sets out what the data actually says, why heat makes it worse, which households carry the most exposure, and the chemical-free physical-barrier layer a household can put in place this week, from a treated long-lasting insecticidal net over the bed to an untreated mesh gazebo over the terrace.
The European Centre for Disease Prevention and Control has now matched a season of sustained heat to a measurable rise in mosquito-borne illness across the continent. In the first week of August 2026, the ECDC's consolidated surveillance data records West Nile virus circulation in 49 NUTS-3 areas across 7 European countries, autochthonous dengue and chikungunya transmission events running ahead of last year's curve in Italy, France and Spain, and the first locally acquired human case in Germany. This piece is the household-readable translation of that data: what the ECDC is actually saying, why heat is the underlying driver, which members of a household carry the most exposure, and the two chemical-free physical-barrier layers a European family can put in place this week.
1. What is happening: the ECDC data, country by country
The headline statistic, as of 5 August 2026, is 49 NUTS-3 areas across 7 European countries with confirmed West Nile virus circulation, the highest geographic spread recorded in the EU/EEA at this point in a transmission season. Italy accounts for 30 of those affected areas, Greece for 8, Romania for 4, France for 2, North Macedonia for 2, Spain for 2, and Germany for 1. The first locally acquired human case in Germany, long anticipated, is now recorded.
The clinical numbers tell the same story in a sharper key. Greece has reported 65 West Nile virus cases in this transmission season up to 5 August, 54 of which presented with severe neurological involvement. Six of those patients have died, all of them over 65. Italy, the largest single national burden in the EU, has reported 94 confirmed cases, the majority neuroinvasive. Romania, France, Spain and North Macedonia have each added a smaller but non-trivial cluster. The ECDC's working multiplier, that for every neuroinvasive case roughly 140 people have been infected, means the true community exposure footprint is much larger than the confirmed-case count suggests.
Dengue, chikungunya and Zika tell a parallel story. Italy, France and Spain have each recorded autochthonous, that is locally acquired rather than travel-imported, transmission of dengue in recent summers, a pattern that was effectively unknown in continental Europe three decades ago. Chikungunya clusters have been recorded in Italy and France. Aedes albopictus, the Asian tiger mosquito, is now established along the Mediterranean coast from Andalusia to the French Riviera to the Italian Adriatic and up into the Po Valley, with expanding range inland.
The ECDC's 29 July 2026 statement, "Sustained heatwaves increase the risk of infectious diseases across Europe; ECDC scales up action", was framed not as a single weather event but as a structural change in transmission season length. The verbatim phrasing the ECDC uses is "continuously higher temperatures of an ever longer duration". That phrasing matters. A single heatwave makes headlines. A multi-year trend of longer and hotter summers lengthens the window in which mosquitoes breed, feed and transmit, and that is what the ECDC is asking public-health authorities and households to plan for.
2. Why heat makes it worse: the biology, briefly
Two mosquito genera drive almost all of the European mosquito-borne disease picture. They are not the same animal, and the protection picture differs by genus.
Culex pipiens, the common house mosquito, is the principal vector of West Nile virus in Europe. It is a crepuscular and nocturnal biter, meaning peak activity at dusk and through the night. It breeds in standing water with organic load, including gutters, blocked drains, unmaintained water butts, flat-roof puddles and forgotten buckets. Culex overwinters as an adult female, so warm winters increase the size of the spring population that begins the season. Hot summers shorten the time it takes for the virus to replicate inside the mosquito, the extrinsic incubation period, which is the biological reason a single hot summer can produce a much larger case count than the same mosquito population would produce in a cooler one.
Aedes albopictus, the Asian tiger mosquito, is the principal vector of dengue, chikungunya and Zika in mainland Europe. It is a daytime biter with peak activity in the morning and late afternoon. It breeds in small artificial containers, plant-pot saucers, water-butts, discarded cups, blocked gutters, and lives a short flight range, typically around 100 metres, meaning that the household is itself the relevant control unit. Aedes eggs survive winter cold and desiccation, so once the species is established in a street, it is essentially permanent.
The heatwave-driven mechanism behind the ECDC's warning is the same in both genera. Warmer winters lift the overwintering survival rate. Hotter summers shorten the extrinsic incubation period, so the virus reaches the salivary gland of the mosquito earlier, the mosquito becomes infectious sooner, and the per-bite transmission probability rises. Longer warm seasons extend the calendar window in which transmission is possible. The same total number of mosquitoes, under hotter and longer conditions, produces more cases.
3. Who is most at risk: families, babies, outdoor sleepers
Three groups in a household carry the highest exposure, and they are not the same as the three groups that carry the highest clinical severity.
Exposure risk is shaped by what the household does outdoors and when. A terrace that is in use from late afternoon through to bedtime is in the active window of both Culex (dusk to night) and Aedes (morning and late afternoon). A child who naps outdoors in the same window, including the common European pattern of afternoon rest on a balcony or in a garden, is exposed to Aedes in particular. An adult who sleeps with an open window on a warm night is exposed to Culex. A family that travels within Europe, to the Mediterranean coast, to the Italian lakes, to the Adriatic, to the Spanish costas, is moving into the geographic area of maximum transmission intensity during the maximum transmission window.
Clinical severity is shaped by age and immune status. West Nile virus is overwhelmingly an adult-severity disease, with neuroinvasive disease and case fatality concentrated in patients over 60. Dengue, in its severe form, is more common in secondary infections and in patients with certain co-morbidities. Chikungunya carries a long-tail arthralgia risk that is severe in older adults. None of these are reasons for panic. They are reasons for structural prevention, set up once, then lived with for the rest of the season.
The household pattern that compounds exposure and severity is the one in which a family spends the warm hours on the terrace, then moves inside to sleep with an open window. The terrace gives Aedes its daytime window, the bedroom with an open window gives Culex its nighttime window, and the same warm night that drives the heatwave also drives the mosquito activity.
4. What protects your family: the physical-barrier layer
The ECDC and the public-health authorities of every country we work with put the same four layers in front of households, and the order matters. They are: source reduction, household-level physical barriers on the bedroom and the terrace, treated long-lasting insecticidal nets where the family chooses to use them, and personal repellents on exposed skin for the gap cases.
Source reduction, the layer that does not involve a purchase
Once a week, empty the plant-pot saucers, clear the gutters, cover the water butts, store buckets and bins upside down, check the flat roof and the balcony for any standing water. The Aedes mosquito flies about 100 metres in its lifetime. If there is no container within that range holding water for more than a week, the local population cannot establish. This is the layer with the largest single impact on the local mosquito population around a household, and it is the one that costs nothing.
The bedroom, at night: a long-lasting insecticidal net over the bed
For families who choose a treated barrier for the bedroom, the World Health Organization publishes a specification for long-lasting insecticidal nets. Mosticare's treated nets, the Cubo Uno, Rondo Uno, Rondo Due, Materasso Uno, Domo, Amaca and Traccia, are built to that specification. They are treated with permethrin under European Union biocidal-product authorisation EU-0026815-0000, granted under Regulation (EU) No 528/2012, the Biocidal Products Regulation. The net is the physical barrier, the treatment is the chemical support, and the family sleeps inside a sealed mesh envelope that excludes Culex pipiens, the nighttime biter that carries West Nile virus, for the entire sleep window.
The net also folds into the heatwave picture. On a warm night, the family can leave the window open for airflow, because the net is the barrier, not the window frame. The net's mesh is fine enough to exclude mosquitoes and coarse enough to allow air movement. A bedroom that was previously closed against mosquitoes on a warm night can now be open for ventilation. The net is doing the work the closed window was previously doing, and the family gets the airflow that the heatwave physiology actually needs.
The terrace, in the evening: an untreated mesh gazebo
For families who do not want a chemical treatment in the space where they eat, and for nurseries and baby rooms where the household has chosen to keep the air zero-chemical, an untreated mesh gazebo or canopy is the corresponding layer for the terrace. Mosticare's Terrazza TE-UNO and Terrazza TE-DUE are untreated mesh enclosures, a free-standing, chemical-free physical barrier that can be set up over a dining table, a sofa or a small garden bed. The Igloo Uno and Igloo Due are smaller untreated mesh enclosures sized for two-person and single-person coverage respectively. The Igloo Bambino is a freestanding untreated mesh canopy sized for a baby travel cot. The Volto is a personal untreated mesh head-and-shoulders enclosure for use on a sun lounger, a fishing seat, an evening patio chair or a balcony.
The framing for these products is a chemical-free physical barrier, and the framing stops there. The Mosticare claim canon guardrail that we apply to every product and to every article is that any reference to permethrin, EU biocidal-product authorisation, or any chemical or regulatory claim is reserved for the treated materials range. Untreated mesh, including the Terrazza, Igloo and Volto families, is described as a zero-chemical physical barrier. The BPR authorisation EU-0026815-0000 is a permethrin authorisation. It does not extend to untreated mesh, gazebos, canopies or travel nets. The regulatory boundary and the product boundary are the same line, and we hold that line in every piece we publish.
Personal repellents, for the gaps
For the gap cases, walking the dog, the school run, an evening drink on a low terrace without a canopy, the public-health authorities recommend an adult skin repellent with DEET, icaridin or IR3535 at the concentration their national authority specifies. These are personal products, applied to exposed skin, and they are the fourth layer, not the first. The first three layers, source reduction, the bedroom net, and the terrace mesh, do the bulk of the work in a typical European household.
What this piece does not promise
A mosquito net reduces bites and indoor entry. It does not prevent or cure disease. It is not a substitute for antimalarial prophylaxis, medical advice, or vaccination where vaccination is available. The World Health Organization fact sheets on West Nile virus and on dengue and severe dengue are explicit on this point, and we say so in every piece we publish on protection.
What a structural layer does, when it is in place before the season, is turn a daily scramble into a habit. That is what the ECDC framing of an ever longer duration is asking of European households. Not panic, not a new gadget every month, but a household that decides once which two rooms need to be sealed off from the mosquito, and then lives the season inside that decision. The bedroom and the terrace, the night and the evening. With source reduction, the structural mesh, and the proportional choice of treated or untreated for the bed and the patio, the ECDC warning becomes a manageable change in household routine rather than a forecast of dread.
If a member of the household develops a sudden high fever, severe joint pain or neurological symptoms during the transmission season, consult a qualified clinician or contact the relevant national public-health authority and mention recent travel and outdoor exposure.
Sources
- European Centre for Disease Prevention and Control. Sustained heatwaves increase the risk of infectious diseases across Europe; ECDC scales up action. News release, 29 July 2026. https://www.ecdc.europa.eu/en/news-events/sustained-heatwaves-increase-risk-infectious-diseases-across-europe-ecdc-scales-action
- CDE News. West Nile virus cases rise across Europe as Greece reports surge and Germany confirms first infection. 6 August 2026. https://cde.news/west-nile-virus-cases-rise-across-europe-as-greece-reports-surge-and-germany-confirms-first-infection/
- European Centre for Disease Prevention and Control. Surveillance and updates on dengue. https://www.ecdc.europa.eu/en/dengue-fever/surveillance-and-disease-data
- European Centre for Disease Prevention and Control. Historical data on local transmission of dengue in the EU/EEA. https://www.ecdc.europa.eu/en/all-topics-z/dengue/surveillance-and-disease-data/autochthonous-transmission-dengue-virus-eueea-previous-years
- World Health Organization. West Nile virus fact sheet. https://www.who.int/news-room/fact-sheets/detail/west-nile-virus
- World Health Organization. Dengue and severe dengue fact sheet. https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue
- European Centre for Disease Prevention and Control. Factsheet, Aedes albopictus. https://www.ecdc.europa.eu/en/disease-vectors/facts/mosquito-factsheets/aedes-albopictus
- European Centre for Disease Prevention and Control. Factsheet, Culex pipiens. https://www.ecdc.europa.eu/en/infectious-disease-topics/related-public-health-topics/disease-vectors/facts/mosquito-factsheets/culex-pipiens
- European Commission. Commission Implementing Regulation (EU) 2022/2330: Union authorisation EU-0026815-0000 for permethrin used in insecticide-treated nets. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32022R2330
- European Parliament and Council. Regulation (EU) No 528/2012, the Biocidal Products Regulation (BPR). https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32012R0528
- Mosticare. Threat-map, dengue in Europe 2026. https://www.mosticare.org/threat-map/dengue
- Mosticare. Threat-map, European mosquito-borne disease overview. https://www.mosticare.org/threat-map
- Euronews. Europe's heatwaves are fuelling infectious diseases, health agency warns. 30 July 2026. https://www.euronews.com/health/2026/07/30/europes-heatwaves-are-fuelling-infectious-diseases-health-agency-warns
Medical disclaimer
This article reports publicly stated assessments from the European Centre for Disease Prevention and Control, the World Health Organization and the cited peer-reviewed and primary-source literature. It does not replace personalised medical advice. In case of symptoms suggestive of dengue, chikungunya, Zika or West Nile virus infection, including sudden high fever, severe joint pain or neurological symptoms, consult a qualified clinician or contact the relevant national public-health authority. The mention of any specific product family by Mosticare is a description of how that product works, not a medical or preventive claim.